BiomarkersHumans1,397 participantsCohort study

Measuring in-vivo tau pathology in the basal forebrain with PET imaging

Figure 1 from Neuropsychopharmacology
Open the figure at full size
Figure 1Harrison et al.

Neuropsychopharmacology

The paper

University of California, Berkeley

Neuropsychopharmacology · 22 Sep 2026

doi.org/10.1038/s41386-026-02564-2PubMed 42773180

More on MAPT